• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

4.560 +0.060 (+1.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
September 19, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
September 18, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
September 16, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
September 14, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR
September 13, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
September 12, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lead Plaintiff Deadline Quickly Approaching in Lifecore Biomedical, Inc. (LFCR) Class Action – Shareholders Should Contact Robbins LLP for Information
September 11, 2024
From Robbins LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
September 10, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
September 10, 2024
Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
September 09, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
September 06, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
September 05, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
September 04, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
September 03, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 31, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 29, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024
Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 27, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
August 26, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
August 26, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
August 26, 2024
From Kirby McInerney LLP
Via Business Wire
News headline image
Pending Lead Plaintiff Deadline in the LFCR Class Action: Robbins LLP Reminds Stockholders With Large Losses of Lifecore Biomedical, Inc. to Seek Counsel
August 23, 2024
From Robbins LLP
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 22, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 21, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
August 21, 2024
From Schall Law
Via GlobeNewswire
News headline image
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
August 19, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Shareholder Rights Law Firm Robbins LLP Urges LFCR Stockholders to Contact the Firm for Information About the Lifecore Biomedical, Inc. Class Action
August 19, 2024
From Robbins LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap